BARC Global Central Laboratories

BARC Global Central Laboratory, now a key component of Cerba Research, is a premier provider of central laboratory services for the global pharmaceutical and biotechnology industries. Established in 1985 and headquartered in Belgium, the company specializes in supporting clinical trials from Phase I through Phase IV with a comprehensive range of routine and highly specialized testing. Its service portfolio includes safety testing, biomarker development, biobanking, and complex logistics management across five continents. BARC is particularly recognized for its expertise in oncology, infectious diseases, and vaccine research, offering standardized data through a unified global platform. In 2020, the company was integrated into the Cerba Research brand to provide a more seamless, multi-specialist approach to clinical pathology and diagnostic solutions.